All In Biotech

Drug Trial Radar · NCT00002122

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

720

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PRIMARY: To determine the efficacy of azithromycin and rifabutin alone and in combination for the prevention of disseminated Mycobacterium avium Complex (MAC) infection in HIV-infected patients. To determine the efficacy of daily versus weekly fluconazole for the prevention of deep fungal infections in this patient population. SECONDARY: To determine the incidence of bacterial (including mycobacterial) infections, cryptosporidiosis, and toxoplasmosis in azithromycin versus non-azithromycin containing regimens. To determine the incidence of oropharyngeal and vaginal candidiasis in patients treated with daily versus weekly fluconazole. To compare survival and outcomes of primary endpoints in the treatment arms.

Conditions

  • Mycoses
  • Mycobacterium Avium-Intracellulare Infection
  • HIV Infections

Interventions

  • AzithromycinDrug

  • RifabutinDrug

  • FluconazoleDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Los Angeles County - USC Med Ctr

    Los Angeles, California

  • UCI Med Ctr

    Orange, California

  • UCSD Treatment Ctr / Dept of Medicine and Pediatrics

    San Diego, California

  • Santa Clara Valley Med Ctr

    San Jose, California

  • Harbor - UCLA Med Ctr

    Torrance, California

  • Georgetown Univ Med Ctr

    Washington D.C., District of Columbia

  • George Washington Univ Med Ctr

    Washington D.C., District of Columbia

  • Univ of Massachusetts Med Ctr

    Worcester, Massachusetts

  • Univ of Pennsylvania

    Philadelphia, Pennsylvania

  • Univ of Texas Southwestern Med Ctr

    Dallas, Texas

  • Baylor College of Medicine

    Houston, Texas

  • Houston Veterans Administration Med Ctr

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.